Find policies, billing codes, payers, states, and providers
CPT 48400: Intraoperative Pancreatic Duct Contrast Study
CPT code 48400 represents the intraoperative injection of contrast into the pancreatic duct for radiographic imaging to assess ductal patency and rule out obstruction during pancreatic surgery. This targeted diagnostic step informs surgical decision-making and can influence immediate intraoperative management to prevent postoperative complications related to ductal obstruction.
Key payers in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The analysis covers clinical context, coding considerations, and payer coverage patterns relevant to hospitals, surgical teams, and billing departments.
Readers will gain an understanding of the clinical purpose of CPT code 48400, the typical care setting (operating room during pancreatic surgery), and the types of surgical scenarios where the code applies. The publication outlines common billing modifiers associated with intraoperative diagnostic procedures, summarizes payer coverage approaches, and highlights benchmarks and policy updates affecting reimbursement and documentation expectations. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 48400 policy alerts
Get alerted when payer policies referencing 48400 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 48400 describes the injection of a radiographic dye into the pancreatic duct to obtain X-ray imaging of the ductal system during pancreatic surgery. This procedure is performed intraoperatively to evaluate patency and detect obstruction of pancreatic fluid flow.
-
Service type: Intraoperative diagnostic imaging procedure involving contrast injection into the pancreatic duct
-
Typical site of service: Operating room during pancreatic surgical procedures